|
C8ORF76 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.395600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.191600E-02 |
| Normal-vs-Stage2 |
5.548200E-01 |
| Normal-vs-Stage3 |
1.164090E-04 |
| Normal-vs-Stage4 |
8.602400E-03 |
| Stage1-vs-Stage2 |
4.652600E-01 |
| Stage1-vs-Stage3 |
4.004500E-02 |
| Stage1-vs-Stage4 |
7.751700E-02 |
| Stage2-vs-Stage3 |
3.707800E-02 |
| Stage2-vs-Stage4 |
8.128500E-02 |
| Stage3-vs-Stage4 |
8.056400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.502920E-03 |
| Normal-vs-AfricanAmerican |
3.344400E-01 |
| Normal-vs-Asian |
2.226200E-02 |
| Caucasian-vs-AfricanAmerican |
8.276600E-01 |
| Caucasian-vs-Asian |
9.356600E-01 |
| AfricanAmerican-vs-Asian |
8.272000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.865900E-02 |
| Normal-vs-Female |
4.750300E-04 |
| Male-vs-Female |
3.212800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.150950E-01 |
| Normal-vs-Age(41-60Yrs) |
2.783300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.091800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.818500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.492500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.649200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.402700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.244000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.052640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.526500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.204800E-04 |
| Classical-VS-Follicular |
5.407600E-02 |
| Classical-VS-Other |
6.745800E-01 |
| Classical-VS-Normal |
1.076990E-03 |
| Tall-VS-Follicular |
1.7157599999984E-05 |
| Tall-VS-Other |
2.227600E-01 |
| Tall-VS-Normal |
3.21320003937586E-09 |
| Follicular-VS-Other |
9.999800E-01 |
| Follicular-VS-Normal |
6.562200E-01 |
| Other-VS-Normal |
9.149000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.147600E-02 |
| Normal-vs-N1 |
1.523750E-03 |
| N0-vs-N1 |
4.579600E-02 |
|
|
